Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Keros Therapeutics Inc (KROS)

149 + Investors. Track Smart Money conviction in KROS. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↓ -13
Streak
1Q ▼
Buyers last Q
45%

Smart Money Signals — KROS

Based on 150 hedge funds · latest filing: 2026 Q1 · updated quarterly

📉

Selling streak — 1 quarter in a row

last 6Q
For 1 consecutive quarter, more hedge funds reduced or closed their KROS positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.
📊

High ownership — 92% of 3.0Y peak

92% of all-time peak
150 funds currently hold this stock — 92% of the 3.0-year high of 163 funds (reached 2025 Q4). Ownership is elevated but not yet at maximum concentration. Room to grow, but watch if the trend reverses.
📉

Outflows — 4% fewer funds vs a year ago

fund count last 6Q
6 fewer hedge funds hold KROS compared to a year ago (-4% decline). When institutions consistently reduce their exposure, it's worth exploring the underlying fundamental reasons driving them away.
🟠

More sellers than buyers — 45% buying

77 buying94 selling
Last quarter: 94 funds reduced or exited vs 77 that bought or added. When more than half of active funds are selling, it's a caution flag — especially if the stock price hasn't moved down yet.
⚠️

Fewer new buyers each quarter (-13 vs last Q)

new funds entering per quarter
Funds opening this position for the first time: 24 → 30 → 40 → 27. Each quarter fewer new institutions are entering. This usually means most funds that wanted in are already in — the stock is well-known but the pool of potential new buyers is shrinking.
🔒

43% of holders stayed for 2+ years

■ 43% conviction (2yr+) ■ 31% medium ■ 26% new
64 out of 150 hedge funds have held KROS for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
💎

Buying through price weakness — shares -9%, value -50%

Value
-50%
Shares
-8%
Last quarter: funds added -9% more shares while total portfolio value only changed -50%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.
📈

Growing discovery — still being found

49 → 24 → 30 → 40 → 27 new funds/Q
New funds entering each quarter: 24 → 30 → 40 → 27. A growing number of institutions are discovering KROS each quarter. The narrative is still spreading — leaving room for ongoing capital accumulation.
🏛️

Veteran-anchored — 53% veterans vs 36% newcomers

■ 53% veterans ■ 12% 1-2yr ■ 36% new
Entry-cohort mix of 156 holders: 82 (53%) are 2+ year veterans, 18 entered 1–2 years ago, and 56 (36%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
✅

Strong quality — 30% AUM from major funds

30% from top-100 AUM funds
41 of 150 holders rank in the top 100 by AUM, accounting for 30% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.
3.6
out of 10
Low Exit Risk
Exit risk score 3.6/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — KROS

In 2026 Q1, 77 hedge funds were net buyers of KROS (27 opened a new position, 50 added to an existing one), while 94 reduced or exited (54 trimmed, 40 sold completely) — a 45% buyer ratio, indicating roughly balanced activity. 30% of total institutional value in KROS is held by top-100 AUM funds, reflecting strong institutional quality. Net fund flow last quarter: -13 funds (more exits than new entries). Total institutional holders: 150.

Hedge Fund Ownership: KROS

How many hedge funds hold KROS — quarterly history vs. share price
Quarterly hedge fund ownership of KROS vs. share price

Market Analysis: KROS

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: KROS

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Keros Therapeutics Inc (KROS) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much KROS has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 85d ago
KROS
-0.4%
XLV
+2.8%

KROS outperformed XLV by -3.2% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 40d ago
KROS
+4.8%
XLV
+3.9%

Since the filing became public, KROS outperformed XLV by +0.9% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

18 top-rated funds 0 high-conviction
Consensus
5.6
/ 10
breadth
×
Elite
0.4
/ 10
conviction
Hedge Fund Positioning: KROS
149 + Investors

Track Smart Money conviction in KROS. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 149 163 -8.59%
13F Shares 19M 21M -8.65%
Total Value $210M $425M -50.44%
New Positions 26 40 -14
Increased Positions 46 40 +6
Closed Positions 40 31 +9
Reduced Positions 54 70 -16
Total Calls 3 5 -40.0%
Total Puts 3 2 50.0%
PUT/CALL Ratio 1.0 0.4 Neutral

Statistics: KROS

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

149 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in KROS. Verified SEC 13F-HR filings.

QUARTER:
Top 25 KROS holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Rangeley Capital, LLC 0.58% 54,400 $601K
2 Nantahala Capital Management, LLC 0.55% 1,360,419 $15.0M
3 Madison Avenue Partners, LP 0.30% 626,583 $6.9M
4 Orbimed Advisors LLC 0.17% 759,155 $8.4M
5 EJF Capital LP 0.12% 15,000 $166K
6 Nebula Research & Development LLC 0.10% 90,406 $1.2M
7 Globeflex Capital L P 0.06% 37,873 $418K
8 ADAR1 Capital Management, LLC 0.06% 97,318 $1.1M
9 Oxford Asset Management LLP 0.05% 11,153 $123K
10 Bridgeway Capital Management, LLC 0.04% 195,017 $2.2M
11 Fox Run Management, L.L.C. 0.04% 22,790 $243K
12 American Financial Group Inc 0.04% 10,105 $112K
13 Prelude Capital Management, LLC 0.04% 46,039 $508K
14 Virtus Investment Advisers, LLC 0.04% 12,676 $140K
15 AlphaQuest LLC 0.04% 32,090 $653K
16 RBF Capital, LLC 0.04% 62,800 $693K
17 Y-Intercept (Hong Kong) Ltd 0.03% 164,483 $1.8M
18 Jacobs Levy Equity Management, Inc 0.03% 706,071 $7.8M
19 PDT Partners, LLC 0.02% 32,744 $361K
20 XTX Topco Ltd 0.02% 88,322 $975K
21 WINTON GROUP Ltd 0.01% 36,433 $402K
22 Martingale Asset Management L P 0.01% 47,596 $525K
23 Federated Hermes, INC. 0.01% 689,229 $7.6M
24 Empowered Funds, LLC 0.01% 145,517 $1.6M
25 Qube Research & Technologies Ltd 0.01% 724,926 $8.0M
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Keros Therapeutics Inc (KROS)

What does the Smart Money Trend signal show for KROS?

Selling streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds reduced or closed their KROS positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.

What is the institutional breadth score for KROS?

More sellers than buyers — 45% buying: Last quarter: 94 funds reduced or exited vs 77 that bought or added. When more than half of active funds are selling, it's a caution flag — especially if the stock price hasn't moved down yet.

What is the fund quality score for KROS holders?

Strong quality — 30% AUM from major funds: 41 of 150 holders rank in the top 100 by AUM, accounting for 30% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held KROS?

43% of holders stayed for 2+ years: 64 out of 150 hedge funds have held KROS for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Keros Therapeutics Inc (KROS) following the 2026 Q1 hedge fund 13F filings?

As of today, KROS has moved +4.8% since the 2026 Q1 13F filing date (May 15, 2026), compared to +3.9% for the XLV sector ETF — an outperformance of +0.9%. Since the quarter end (March 31, 2026), KROS has gained -0.4% vs +2.8% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →